219 related articles for article (PubMed ID: 31636912)
1. Challenges constraining availability and affordability of insulin in Bengaluru region (Karnataka, India): evidence from a mixed-methods study.
Satheesh G; Unnikrishnan MK; Sharma A
J Pharm Policy Pract; 2019; 12():31. PubMed ID: 31636912
[TBL] [Abstract][Full Text] [Related]
2. Insulin prices, availability and affordability: a cross-sectional survey of pharmacies in Hubei Province, China.
Liu C; Zhang X; Liu C; Ewen M; Zhang Z; Liu G
BMC Health Serv Res; 2017 Aug; 17(1):597. PubMed ID: 28836974
[TBL] [Abstract][Full Text] [Related]
3. Challenges constraining access to insulin in the private-sector market of Delhi, India.
Sharma A; Kaplan WA
BMJ Glob Health; 2016; 1(3):e000112. PubMed ID: 28588966
[TBL] [Abstract][Full Text] [Related]
4. Availability, price and affordability of essential medicines for managing cardiovascular diseases and diabetes: a statewide survey in Kerala, India.
Satheesh G; Sharma A; Puthean S; Ansil T P M; E J; Raj Mishra S; Unnikrishnan MK
Trop Med Int Health; 2020 Dec; 25(12):1467-1479. PubMed ID: 32959441
[TBL] [Abstract][Full Text] [Related]
5. Access to Insulin Products in Pakistan: A National Scale Cross-Sectional Survey on Prices, Availability, and Affordability.
Saeed A; Lambojon K; Saeed H; Saleem Z; Anwer N; Aziz MM; Ji W; Liu W; Chen C; Yang C; Fang Y; Babar ZU
Front Pharmacol; 2022; 13():820621. PubMed ID: 35431962
[No Abstract] [Full Text] [Related]
6. Challenges constraining insulin access in Nepal-a country with no local insulin production.
Sharma A; Bhandari PM; Neupane D; Kaplan WA; Mishra SR
Int Health; 2018 May; 10(3):182-190. PubMed ID: 29617832
[TBL] [Abstract][Full Text] [Related]
7. Where are we now: assessing the price, availability and affordability of essential medicines in Delhi as India plans free medicine for all.
Kotwani A
BMC Health Serv Res; 2013 Jul; 13():285. PubMed ID: 23885985
[TBL] [Abstract][Full Text] [Related]
8. Evaluating drug prices, availability, affordability, and price components: implications for access to drugs in Malaysia.
Babar ZU; Ibrahim MI; Singh H; Bukahri NI; Creese A
PLoS Med; 2007 Mar; 4(3):e82. PubMed ID: 17388660
[TBL] [Abstract][Full Text] [Related]
9. Insulin prices, availability and affordability in 13 low-income and middle-income countries.
Ewen M; Joosse HJ; Beran D; Laing R
BMJ Glob Health; 2019; 4(3):e001410. PubMed ID: 31263585
[TBL] [Abstract][Full Text] [Related]
10. Baseline assessment of WHO's target for both availability and affordability of essential medicines to treat non-communicable diseases.
Ewen M; Zweekhorst M; Regeer B; Laing R
PLoS One; 2017; 12(2):e0171284. PubMed ID: 28170413
[TBL] [Abstract][Full Text] [Related]
11. Availability, affordability and price components of insulin products in different-level hospital pharmacies: Evidence from two cross-sectional surveys in Nanjing, China.
Wang L; Dai L; Liu H; Dai H; Li X; Ge W
PLoS One; 2021; 16(8):e0255742. PubMed ID: 34383816
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of availability, price, and affordability of cardiovascular, diabetes, and global medicines in Abuja, Nigeria.
Osuafor NG; Ukwe CV; Okonta M
PLoS One; 2021; 16(8):e0255567. PubMed ID: 34383799
[TBL] [Abstract][Full Text] [Related]
13. Access to essential medicines for diabetes care: availability, price, and affordability in central Ethiopia.
Deressa HD; Abuye H; Adinew A; Ali MK; Kebede T; Habte BM
Glob Health Res Policy; 2024 Apr; 9(1):12. PubMed ID: 38584277
[TBL] [Abstract][Full Text] [Related]
14. Evaluating access to essential medicines for treating childhood cancers: a medicines availability, price and affordability study in New Delhi, India.
Faruqui N; Martiniuk A; Sharma A; Sharma C; Rathore B; Arora RS; Joshi R
BMJ Glob Health; 2019; 4(2):e001379. PubMed ID: 31139456
[TBL] [Abstract][Full Text] [Related]
15. Access to paediatric essential medicines: a survey of prices, availability, affordability and price components in Shaanxi Province, China.
Wang X; Fang Y; Yang S; Jiang M; Yan K; Wu L; Lv B; Shen Q
PLoS One; 2014; 9(3):e90365. PubMed ID: 24595099
[TBL] [Abstract][Full Text] [Related]
16. Access to Essential Medicines for Diabetes Care: Availability, Price, and Affordability in Central Ethiopia.
Deressa HD; Abuye H; Adinew A; Ali MK; Kebede T; Habte BM
Res Sq; 2023 Dec; ():. PubMed ID: 38106116
[TBL] [Abstract][Full Text] [Related]
17. A comprehensive survey of cancer medicines prices, availability and affordability in Ghana.
Ocran Mattila P; Biritwum RB; Babar ZU
PLoS One; 2023; 18(5):e0279817. PubMed ID: 37134123
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of prices, availability and affordability of essential medicines in Lahore Division, Pakistan: A cross-sectional survey using WHO/HAI methodology.
Saeed A; Saeed H; Saleem Z; Fang Y; Babar ZU
PLoS One; 2019; 14(4):e0216122. PubMed ID: 31022276
[TBL] [Abstract][Full Text] [Related]
19. WHO key access antibiotics price, availability and affordability in private sector pharmacies in Pakistan.
Saleem Z; Saeed H; Akbar Z; Saeed A; Khalid S; Farrukh L; Irfan A; Anam A; Hassali MA; Rasheed H; Babar ZU
Cost Eff Resour Alloc; 2021 Feb; 19(1):10. PubMed ID: 33593366
[TBL] [Abstract][Full Text] [Related]
20. Evaluating medicine prices, availability and affordability in Bangladesh using World Health Organisation and Health Action International methodology.
Kasonde L; Tordrup D; Naheed A; Zeng W; Ahmed S; Babar ZU
BMC Health Serv Res; 2019 Jun; 19(1):383. PubMed ID: 31196078
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
